Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment

Must Read

infected animals was confirmed with a clinical dosage of regdanvimab (CT-P59)1
Incheon, South Korea–(Antara/Business Wire.

Latest News

Birth of Sumatran elephant calf marks Indonesia’s Independence Day

Jakarta (ANTARA) - The Indonesian Ministry of Forestry announced the birth of a critically endangered Sumatran elephant (Elephas maximus...

More Articles Like This